Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-11-09 | Miscellaneous 2 | ETA2023

Thyroid dysfunctions in covid-19 patients: impact on in-hospital outcomes and long-covid symptoms

Campi Irene , Lugaresi Marina , Battista Perego Giovanni , Fratianni Gerardina , Balla Eva , Bulgarelli Ilaria , Persani Luca , Fugazzola Laura

Context: A variety of thyroid disorders have been documented in COVID-19 patients, including non-thyroidal illness syndrome (NTIS), subacute thyroiditis (SAT) and thyrotoxicosis.Objectives: To investigate the relationship between thyroid dysfunctions observed during hospitalisation and COVID-19-related morbidity and mortality.Study design and setting: Prospective cohort study on patients admitted in a tertiary hospital for COVID-19...

ea0094s4.3 | Hacking the reproductive clock | SFEBES2023

The genetics of the ageing ovary

Stankovic Stasa , Perry John , Murray Anna , Shekari Saleh , Hoffmann Eva , Qin Huang Qin , Martin Hilary , Hurles Matthew

Menopause timing is highly variable, having a direct effect on reproductive lifespan, fertility and health outcomes in later life. Endocrine and imaging tests only record changes in ovarian function that have already taken place, thus disabling early prediction and identification of women with reduced reproductive lifespan. Human genetic studies have attempted to overcome this problem by identifying genetic markers associated with menopause timing and fertility. Using data fro...

ea0097012 | Section | BES2023

Endocrine manifestations in 22q11.2 deletion syndrome: a retrospective single center cohort study

Eva Soubry , Karel David , Ann Swillen , Elfi Vergaelen , Op de Beeck Marie Docx , Margo Hulsmans , Sara Charleer , Brigitte Decallonne

Introduction and objective: Patients with the 22q11.2 deletion syndrome (22q11DS) frequently display cardiological and psychiatric diseases, but are also at increased risk for endocrine manifestations. The aim of this study was to evaluate the screening, prevalence, and management of hypoparathyroidism and thyroid disease in patients with 22q11DS, to evaluate the metabolic profile and to compare these results with current literature and guidelines.<p class...

ea0099p502 | Endocrine-Related Cancer | ECE2024

Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients

Mulders Merijn , van Velthuysen M F , Roes Eva Maria , Hofland Leo , de Herder Wouter W , Hofland Hans

Background: Neuroendocrine tumors (NET) are malignant neoplasms that can be associated with specific hormonal syndromes. We describe a novel syndrome of postmenopausal vaginal bleeding and ovarian estradiol overproduction due to ovarian NET localizations.Methods: A clinical workup was performed for 2 index patients with ovarian metastases of small bowel neuroendocrine tumors and symptoms of postmenopausal vaginal bleeding. Ovarian tissue was collected af...

ea0099ep282 | Adrenal and Cardiovascular Endocrinology | ECE2024

Description of the x-linked adrenoleukodystrophy cohort from the csur unit of adult metabolic disorders at virgen del rocio university hospital (seville)

Gonzalez Gracia Lucia , Dios Fuentes Elena , Benitez Avila Rosa , Oulad Ahmed Bothayna , Soto Moreno Alfonso , Venegas Moreno Eva

Introduction and Objective: X-linked adrenoleukodystrophy (X-ALD) is a rare disease caused by a mutation in the ABCD1 gene (Xq28). It is characterized by the absence of very long-chain fatty acids (VLCFAs) degradation, leading to their accumulation primarily in the central and peripheral nervous system, adrenal cortex, and gonads. It presents a variable clinical spectrum and prognosis. The aim of our study is to describe the characteristics of all X-ALD patients under follow-u...

ea0099ep255 | Calcium and Bone | ECE2024

An interesting case of co-existence of autosomal dominant hypocalcemia 1 with chronic myelogenous leukemia

Eleni Chondrogianni Maria , Kyrou Ioannis , Papadopoulou Anna , Kaperda Aikaterini , Diamantopoulos Panagiotis , Angelousi Anna , Randeva Harpal , Kassi Eva

Introduction: Autosomal dominant hypocalcemia (ADH) type 1 is a rare form of hypoparathyroidism, caused by heterozygous, inherited or de novo, activating mutations in the CASR. CASR is also expressed in the kidney and activating mutations lead to decreased calcium renal absorption. Activating mutations in the CasR, inhibits salt transport, leading to Bartteŕs syndrome (BS) type V which can co-exist with ADH1. Chronic myeloid leukemia (Cml) is characterized by the...

ea0099ep424 | Calcium and Bone | ECE2024

Body composition of the arms as an index of bone quality

Eleni Chondrogianni Maria , Kyrou Ioannis , Androutsakos Theodoros , Papadopoulou-Marketou Nektaria , Panagaki Maria , Polichroniadi Despina , Kaltsas Gregory , Randeva Harpal , Kassi Eva

Introduction: Traditionally, obesity is thought to exert a positive impact on bone mineral density (BMD). However, the effect of adipose tissue on bone health is under investigation. Trabecular bone score (TBS) is a measure of bone texture, providing information on bone quality and microarchitecture, independently of BMD. Lower values of TBS indicate a worsening in bone quality and amplify fracture risk. Herein, we aimed to investigate the association of body composition and b...

ea0051oc2.1 | Oral Communications 2 | BSPED2017

Discordant TSH measurements in an euthyroid child due to a homozygous TSHbeta subunit gene variant with variable immunoreactivity

van Walree Eva , Hendriks A Emile J , Moran Carla , Nicholas Adeline K , Lyons Greta , McGowan Anne , Halsall David , Oddy Sue , Chatterjee V Krishna , Schoenmakers Nadia

Introduction: Thyroid function tests are frequently undertaken in children with non-specific symptoms suggestive of thyroid dysfunction. Infrequently, susceptibility of automated thyroid hormone assays to interference may generate misleading results, with the potential for inappropriate diagnosis and management. We report an unusual case with apparent subclinical hyperthyroidism, due to negative interference in particular TSH assay platforms, with an underlying genetic basis.<...

ea0081rc5.4 | Rapid Communications 5: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2022

Empagliflozin induces endocan expression and alleviates NAFLD through regulation of NF-κB pathway

Nasiri-Ansari Narjes , Kyriakopoulos Georgios , Kyrou Ioannis , Flessa Christina-Maria , Lianou Maria , Karapanagioti Angeliki , Kaltsas Gregory , Papavassiliou Athanasios G , Randeva Harpal S , Kassi Eva

Introduction: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disorders. Endocan is a novel molecule of endothelial dysfuction which is expressed in liver. SGLT2i have been reported to improve NAFLD through amelioration of inflammation. While there are contradictory results regarding the serum endocan levels in NAFLD patients, data regarding endocan expression in liver tissue are limited. Aim: Herein, we aimed to investigat...

ea0081ep691 | Pituitary and Neuroendocrinology | ECE2022

Genomic and epigenomic aspects of Aspirin antitumoral effect in pituitary adenoma

Szabo Borbala , Krokker Lilla , Meszaros Katalin , Saskői Eva , Nemeth Krisztina , Szabo Pal , Szucs Nikolette , Czirjak Sandor , Patocs Attila , Butz Henriett

Background: In our previous works the interdependence of DNA demethylation with proliferation and differentiation of pituitary neuroendocrine tumours (PitNET) and the inhibitory effect of Aspirin on pituitary cell proliferation were demonstrated. Although the role of Aspirin in epigenetic regulation was described in other malignancies, its correlation with pituitary tumorigenesis is currently unknown.Our objective: was to investigate the genomic and epig...